CIK 0001783183
- Non-accelerated filer
- Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824151574
- Phone
- +1 877-742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 117,600 shares at $24.86 ($2,923,642)
- 4 Open-market buy 10% owner bought 60,600 shares at an average $24.58 ($1,489,264)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,052,631 shares at $19.00 ($19,999,989)
- 4 Open-market buy 10% owner bought 1,052,631 shares at $19.00 ($19,999,989)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 12 · 224 filings